Vaccine News and Research

Latest Vaccine News and Research

Promising vaccine may protect against the Klebsiella superbug

A powerful superbug, a hypervirulent form of the bacteria Klebsiella pneumoniae, is a very difficult to curb infection. It causes a variety of infections including rare but life-threatening liver, respiratory tract, bloodstream and other infections.

28 Aug 2019

Early detection method for pinpointing molecular signatures of Lyme disease

When researchers examined the mitochondrial DNA of Ötzi, a man entombed in ice high in the Tyrolean Alps some 5,300 years ago, they made a startling discovery.

26 Aug 2019

Scientists create first detailed map of individual malaria parasite behavior

The first detailed map of individual malaria parasite behavior across each stage of its complicated life cycle has been created by scientists.

26 Aug 2019

Individual’s trust and proximity to disease outbreak may affect vaccination attitudes

An individual’s trust in institutions such as the CDC, and how close they live to a recent measles outbreak, may affect their attitudes on measles vaccination, according to a study published August 28, 2019 in the open-access journal PLOS ONE by Florian Justwan of the University of Idaho, USA, and colleagues.

From PLOS ONE 26 Aug 2019

Skin patch delivers melanoma medication in one minute

Researchers have developed a fast-acting skin patch that can deliver medication to treat melanoma in one minute.

26 Aug 2019

Vaccinating older adults against shingles is likely cost-effective in Canada

Vaccinating older adults against shingles in Canada is likely cost-effective, according to a study in CMAJ, and the Shingrix vaccine appears to provide better protection than the Zostavax vaccine.

26 Aug 2019

New type of vaccine targets deadly tuberculosis

Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis (TB), the world's top infectious disease killer.

25 Aug 2019

Nigeria on the brink of being polio free

There have been no reported cases of polio in Nigeria for the last three years and the nation may soon be declared free of the crippling viral disease. According to the World Health Organization (WHO), Nigeria has come a long way since 2012 when it had almost half of the global number of polio cases.

21 Aug 2019

Measles back in UK three years after elimination

The United Kingdom was declared to be free of measles infection three years back in 2016 by the World Health Organization (WHO). In a recent development, due to the increasing number of cases of measles among unvaccinated children, the WHO has declared that UK can no longer be called measles-free.

20 Aug 2019

A brush with a notorious cat, my rabies education and the big bill that followed

I was just petting an orange tabby cat in my Falls Church, Va., neighborhood, a cat I’d never met before. He was very cute. And he was purring and butting his head against my hand. Until he wasn't.

20 Aug 2019

Religion may play role in HPV vaccination rate for female college students

It's been more than a decade since a vaccine was introduced to prevent contraction of human papillomavirus, the most common sexually transmitted disease in the U.S.

19 Aug 2019

Researchers gain new insights into the mechanism of vaccine-induced T cell immunity

A team led by the Walter Reed Army Institute of Research has gained new insights into the mechanism of vaccine-induced T cell immunity utilizing single-cell RNA sequencing and metabolic profiling techniques.

16 Aug 2019

Mortality risk from yellow fever can be identified sooner

Approximately ten out of every 100 people who are bitten by mosquitos infected by the yellow fever virus develop symptoms of the disease. Although most infected people do not develop the disease, it is lethal to approximately 40% of those who do.

14 Aug 2019

Chlamydia vaccine shows promise after a successful clinical trial

A vaccine against the sexually transmitted infection (STI) chlamydia is now a substantial step closer to reality after successfully passing its Phase 1 clinical trial.

14 Aug 2019

Deadly protein combination reveals new drug targets for viral infections

New research from Cornell University details how two highly lethal viruses have greater pathogenic potential when their proteins are combined.

14 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

Ohio State research in flu protection starts at county fairs

For researchers with The Ohio State University College of Veterinary Medicine, the work to identify new flu strains and increase the effectiveness of the flu vaccine begins in an unlikely place – pig barns at state and county fairs nationwide.

12 Aug 2019

NIH-funded clinical trial will evaluate seasonal influenza vaccines with two experimental adjuvants

An early-stage clinical trial is evaluating two licensed seasonal influenza vaccines, administered with or without novel adjuvants, for their safety and ability to generate an immune response.

9 Aug 2019

Study reveals Lassa virus' soft spot

As this year's Lassa fever outbreak in Nigeria is finally ebbing, the total tally came to more than 600 infected people, one-quarter of them dead. Thousands more die each year, uncounted in rural villages throughout West Africa.

9 Aug 2019

NIH awards $2.3 million for pilot project to develop opioid vaccine

The NIH has awarded $2.3M for a pilot project, led by Boston Children's Hospital, to develop a vaccine that would protect people with opioid use disorder against an accidental fentanyl overdose.

8 Aug 2019